Why UK equities?
With thousands of businesses from 60 countries around the world listed in the UK, its stock market remains one of the most exciting choices for investors today.
Deep, liquid markets and world-leading regulation, corporate governance and legal and professional services support make UK equities a must-have for any global equity portfolio.
COVID-19 Impact on UK Equities
During the latest webinar, Chris St John and Dan Harlow discussed what impact the COVID-19 pandemic has had on their portfolios and the wider market, and what they believe this could mean for UK equities.
Our UK equity team’s expertise spans the entire market cap spectrum.
Whether you’re aiming to capture growth from the dynamic small cap sector, benefit from exciting opportunities offered by innovative mid-cap companies, or gain exposure to internationally-focused, mega-cap stocks in the FTSE 100 Index, we have a range of funds to cover your needs.
UK equities in focus
dedicated UK equities managers
years of experience*
UK assets under management
Source: AXA IM as 31/08/2019
*Average years of experience of a Portfolio Manager
41 insights found
Home advantage for UK investors
UK Equities Webinar with Chris St John, Dan Harlow & Simon Young
UK companies: why now?
In this piece, we aim to set out some of the core arguments for investing in the UK today, and why UK-based investors in particular should be considering their home market.
UK Mid Cap strategy: Mergers and acquisitions remains a feature of the UK market
Equity markets, particularly in the UK, rose strongly in December, buoyed both by optimism related to the imminent rollout of the Pfizer and Astrazeneca Covid vaccine and news that the UK and Europea ...
UK Multi-Cap strategy: We continue to focus on companies where balance sheet strength is supportive of that growth
The initial announcement, from Pfizer, catalysed a dramatic ‘style rotation’ as investors became immediately more optimistic about a global economic recovery.
UK Mid Cap strategy: Equity markets rose strongly in November
Equity markets rose strongly in November following the release of positive late stage trial data from three Coronavirus vaccine candidates.
‘Cheap’ UK equities a hunting ground for bargain seekers
For much of the past four years, the UK has been unloved, under-owned and undervalued.